Cardiovascular ACE2 receptor expression in patients undergoing heart transplantation

Cardiovascular ACE2 receptor expression in patients undergoing heart transplantation

Abstract Aims Membrane‐bound angiotensin‐converting enzyme (ACE)2 is the main cellular access point for SARS‐CoV‐2, but its expression and the effect of ACE inhibition have not been assessed quantitatively in patients with heart failure. The aim of this study was to characterize membrane‐bound ACE2...

Full description

Bibliographic Details
Main Authors:	Johannes Bargehr, Patrick Rericha, Alex Petchey, Maria Colzani, Georgia Moule, Marie Chet Malgapo, Doris Rassl, Jason Tarkin, Greg Mellor, Fotis Sampaziotis, Teresa Brevini, Laure Gambardella, Martin R. Bennett, Sanjay Sinha
Format:	Article
Language:	English
Published:	Wiley 2021-10-01
Series:	ESC Heart Failure
Subjects:	COVID‐19; SARS‐CoV‐2; Heart failure; Heart transplantation; ACE inhibitor
Online Access:	https://doi.org/10.1002/ehf2.13528

Similar Items

COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES
by: Y. A. Karpov
Published: (2015-12-01)

ACE inhibitors in the treatment of ischemicheart disease and prevention of its complications (review)
by: V V Schekotov
Published: (2004-03-01)

Selection of an ACE inhibitor in clinical practice
by: OD Ostroumova, et al.
Published: (2014-12-01)

Role of Angiotensin-Converting Enzyme (ACE) gene polymorphism and ACE activity in predicting outcome after acute myocardial infarction
by: Nagaraja Moorthy, et al.
Published: (2021-02-01)

Human Tissue Angiotensin Converting Enzyme (ACE) Activity Is Regulated by Genetic Polymorphisms, Posttranslational Modifications, Endogenous Inhibitors and Secretion in the Serum, Lungs and Heart
by: Viktor Bánhegyi, et al.
Published: (2021-07-01)

P38 MAPK activated ADAM17 mediates ACE2 shedding and promotes cardiac remodeling and heart failure after myocardial infarction
by: Qi Chen, et al.
Published: (2023-04-01)

An ACE2-Alamandine Axis Modulates the Cardiac Performance of the Goldfish <i>Carassius auratus</i> via the NOS/NO System
by: Mariacristina Filice, et al.
Published: (2022-04-01)

ACE inhibitor lisinopril influence on left ventricular diastolic dysfunction and endothelial response in hypertensive patients with or without chronic heart failure
by: A. D. Kuimov, et al.
Published: (2004-06-01)

Clinical Impact of ACE-I/ARB for Conservatively Treated Patients with Moderate to Severe Mitral Regurgitation: A Single Center Observational Study
by: Robert Uzel, et al.
Published: (2023-04-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

EVIDENCE-BASED CHOICE OF ACE INHIBITORS
by: G. E. Gendlin, et al.
Published: (2012-08-01)

ACE İnhibitörüne Bağlı Öksürük Senkopu
by: Ayşe KOÇ, et al.
Published: (2015-10-01)

Prevalence, feature and treatment in a cohort of patients hospitalized for heart failure with preserved systolic function: data from the PRESYF-HF Toscana study
by: Paolo Biagi, et al.
Published: (2013-04-01)

Vitamin D improves hepatic alterations in ACE1 and ACE2 expression in experimentally induced metabolic syndrome
by: Sara Mohater, et al.
Published: (2023-09-01)

Aliskiren-Loaded Nanoparticles Downregulate (Pro)renin Receptor and ACE Gene Expression in the Heart of Spontaneously Hypertensive Rats: Effect on NADPH Oxidase
by: Andrej Barta, et al.
Published: (2024-01-01)

Single-cell analysis of adult human heart across healthy and cardiovascular disease patients reveals the cellular landscape underlying SARS-CoV-2 invasion of myocardial tissue through ACE2
by: Cong Chen, et al.
Published: (2023-05-01)

EFFECT OF ACE INHIBITOR AND RECEPTOR ANTAGONIST OF TYPE 1 ANGIOTENSIN II ON HEMODYNAMICS AND MORPHO-FUNCTIONAL PARAMETERS OF THE HEART IN PATIENTS WITH HEART FAILURE ON A BACKGROUND OF CORONARY HEART DISEASE COMBINED WITH TYPE 2 DIABETES
by: Z. V. BITAROVA, et al.
Published: (2017-09-01)

ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy
by: Zohreh Rahimi
Published: (2012-10-01)

Cough Syncope due to ACE Inhibitor
by: Filiz Koc, et al.
Published: (2015-09-01)

The association of ACE1, ACE2, TMPRSS2, IFITM3 and VDR polymorphisms with COVID-19 severity
by: Zorana Dobrijević, et al.
Published: (2022-06-01)

ACE2 Receptor and Its Isoform Short-ACE2 Are Expressed on Human Spermatozoa
by: Marina Ramal-Sanchez, et al.
Published: (2022-03-01)

Genotype variation of ACE and ACE2 genes affects the severity of COVID-19 patients
by: Ingrid Faustine, et al.
Published: (2023-09-01)

Alu insertion/deletion of ACE gene polymorphism might not affect significantly the serum bradykinin level in hypertensive patients taking ACE inhibitors
by: Widodo, et al.
Published: (2017-04-01)

Continue ACE inhibitors / ARB’S till further evidence in coronavirus disease 2019 (COVID-19)
by: Sandeep Bansal, et al.
Published: (2020-05-01)

Association of insertion–deletion polymorphism of ACE gene and Alzheimer’s disease in Egyptian patients
by: Omayma M. Hassanin, et al.
Published: (2014-10-01)

Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis
by: Sarah Seeherman, et al.
Published: (2021-02-01)

Pharmacoepidemiological study of recommendations of diuretics for the treatment of hypertension in the outpatient setting
by: A I Ponomareva, et al.
Published: (2014-09-01)

ELITE II and Val-HeFT are different trials: together what do they tell us?
by: Dickstein Kenneth
Published: (2001-09-01)

Association between ACE gene polymorphisms and risk of suicide
by: Soudeh ghafouri-fard, et al.
Published: (2024-06-01)

Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19
by: Artemio García-Escobar, et al.
Published: (2022-01-01)

Biological sex differences in renin angiotensin system enzymes ACE and ACE2 regulate normal tissue response to radiation injury
by: Guru Prasad Sharma, et al.
Published: (2023-05-01)

ACE Inhibitory Activity and Functional Group Analysis of SolventPartitioned Fractions of Eleusine indica
by: Jade Celon Cometa, et al.
Published: (2020-04-01)

Treatment and Management of Hypertension by Targeting ACE Inhibitors: in silico Approach
by: Seema Bawa, et al.
Published: (2019-03-01)

Thymosin-α1 binds with ACE and downregulates the expression of ACE2 in human respiratory epithelia
by: Yu-Hang Zhang, et al.
Published: (2022-02-01)

Role of ACE2 Gene Expression in Renin Angiotensin System and Its Importance in Covid-19: In Silico Approach
by: Sevgi Kalkanli Tas, et al.
Published: (2020-10-01)

ACE inhibitors as a risk factor for hypoglycemia
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2011-12-01)

Genotype-specific reference intervals for serum ACE
by: Celine Gerin, et al.
Published: (2009-10-01)

MICROCIRCULATION IN CHRONIC HEART FAILURE PATIENTS TREATED WITH ACE INHIBITORS AND DIURETICS
by: Yu. I. Gurfinkel, et al.
Published: (2011-04-01)

Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID‐19: A meta‐analysis
by: Md. Abdul Aziz, et al.
Published: (2022-11-01)